Biolojic Design
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Faneuil Hall Market Pl Fl 3, Boston, M...Website
www.biolojic.comRevenue
<$5 MillionIndustry
About Biolojic Design
Biolojic Design is pioneering advancements in antibody technology, focusing on the engineering of epitope-specific antibodies and multibodies to address challenges in treating autoimmune diseases and cancers. Utilizing a machine learning platform, they create dynamic, programmable antibodies that offer precise molecular effects with enhanced efficacy and reduced toxicity. Their pipeline emphasizes computationally designed antibodies targeting validated biological pathways in autoimmune diseases and immuno-oncology. The company aims to redefine drug design by integrating biology, AI, and drug development through a talented team of experts.Explore more
Biolojic Design Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Biolojic Design
Compare insights from companies similar to Biolojic Design, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Biolojic Design Tech Stack
A closer look at the technologies used by Biolojic Design
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biolojic Design
Sign Up For FreeTo access detailed company insights
Biolojic Design is pioneering advancements in antibody technology, focusing on the engineering of epitope-specific antibodies and multibodies to address challenges in treating autoimmune diseases and cancers. Utilizing a machine learning platform, they create dynamic, programmable antibodies that offer precise molecular effects with enhanced effica... Read More
